OncoVista Innovative Therapies, Inc.
OVIT
$0.0001
-$0.0001-50.00%
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.65M | 2.66M | 1.89M | 1.88M | 631.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.40M | 3.37M | 2.57M | 2.55M | 1.26M |
| Operating Income | -3.40M | -3.37M | -2.57M | -2.55M | -1.26M |
| Income Before Tax | -3.27M | -2.72M | -2.51M | -2.54M | -1.35M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.27 | -2.72 | -2.51 | -2.54 | -1.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.27M | -2.72M | -2.51M | -2.54M | -1.35M |
| EBIT | -3.40M | -3.37M | -2.57M | -2.55M | -1.26M |
| EBITDA | -3.40M | -3.37M | -2.57M | -2.55M | -1.26M |
| EPS Basic | -0.15 | -0.12 | -0.12 | -0.12 | -0.06 |
| Normalized Basic EPS | -0.09 | -0.08 | -0.07 | -0.07 | -0.04 |
| EPS Diluted | -0.15 | -0.12 | -0.12 | -0.12 | -0.06 |
| Normalized Diluted EPS | -0.09 | -0.08 | -0.07 | -0.07 | -0.04 |
| Average Basic Shares Outstanding | 88.80M | 87.37M | 86.99M | 86.60M | 86.51M |
| Average Diluted Shares Outstanding | 88.80M | 87.37M | 86.99M | 86.60M | 86.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |